Regeneron Pharmaceuticals, Inc.
Humanized T cell co-receptor mice
Last updated:
Abstract:
The invention provides genetically modified non-human animals that express chimeric human/non-human T cell co-receptor polypeptides (e.g., CD4, CD8.alpha., CD8.beta.), as well as embryos, cells, and tissues comprising the same. Also provided are constructs for making said genetically modified animals and methods of making the same.
Status:
Grant
Type:
Utility
Filling date:
6 Oct 2017
Issue date:
3 Nov 2020